🧵 Zentalis Pharmaceuticals Cuts Workforce by 40% to Advance WEE1 Inhibitor to Registrational Trial
#ZentalisPharmaceuticals #Layoffs #Wee1Inhibitor #Azenosertib #ClinicalTrials #CancerTreatment #BiotechIndustry
#ZentalisPharmaceuticals #Layoffs #Wee1Inhibitor #Azenosertib #ClinicalTrials #CancerTreatment #BiotechIndustry